Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin

Purpose: Delineate the stereospecific pharmacokinetics and pharmacodynamics of the chiral flavonoids pinocembrin and pinostrobin. Objective: Characterize for the first time the stereoselective pharmacokinetics of two flavonoids, pinocembrin and pinostrobin and their bioactivity in several in vitro a...

Full description

Saved in:
Bibliographic Details
Main Authors: Casey L. Sayre (Author), Samaa Alrushaid (Author), Stephanie E. Martinez (Author), Hope D. Anderson (Author), Neal M. Davies (Author)
Format: Book
Published: Frontiers Media S.A., 2015-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6b75ec7be93f488d97ad1cb4f9a2a8d3
042 |a dc 
100 1 0 |a Casey L. Sayre  |e author 
700 1 0 |a Samaa Alrushaid  |e author 
700 1 0 |a Stephanie E. Martinez  |e author 
700 1 0 |a Hope D. Anderson  |e author 
700 1 0 |a Neal M. Davies  |e author 
245 0 0 |a Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin 
260 |b Frontiers Media S.A.,   |c 2015-09-01T00:00:00Z. 
500 |a 10.18433/J3BK5T 
500 |a 1482-1826 
520 |a Purpose: Delineate the stereospecific pharmacokinetics and pharmacodynamics of the chiral flavonoids pinocembrin and pinostrobin. Objective: Characterize for the first time the stereoselective pharmacokinetics of two flavonoids, pinocembrin and pinostrobin and their bioactivity in several in vitro assays with relevant roles in heart disease, colon cancer, and diabetes etiology and pathophysiology. Methods: Chiral flavonoids were intravenously and orally administered to male Sprague-Dawley rats. Concentrations in serum and urine were characterized via stereospecific HPLC or LC/MS. Pure enantiomeric forms of each flavonoid were tested, where possible, to identify the stereospecific contribution to bioactivity in comparision to their racemates. Results:  Short half-lives (0.2-6 h) in serum were observed, while a better estimation of half-life (3-26 h) and other pharmacokinetic parameters were observed using urinary data. The flavonoids are predominantly excreted via non-renal routes (fe values of 0.3-4.6 %), and undergo rapid and extensive phase II metabolism. Chiral differences in the chemical structure of these compounds result in significant pharmacodynamic differences. Conclusion: The importance of understanding the stereospecific pharmacokinetics and pharmacodynamics of two chiral flavonoids were delineated. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmaceutical Sciences, Vol 18, Iss 4 (2015) 
787 0 |n https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/24981 
787 0 |n https://doaj.org/toc/1482-1826 
856 4 1 |u https://doaj.org/article/6b75ec7be93f488d97ad1cb4f9a2a8d3  |z Connect to this object online.